⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AYTU News
AYTU BioPharma, Inc. Common Stock
Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
accessnewswire.com
AYTU
Form 8-K
sec.gov
AYTU
Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results
accessnewswire.com
AYTU
Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026
accessnewswire.com
AYTU
Form 8-K
sec.gov
AYTU
Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
accessnewswire.com
AYTU
Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026
accessnewswire.com
AYTU
Aytu BioPharma Recaps Investor Day Held on January 20, 2026
accessnewswire.com
AYTU
Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA
accessnewswire.com
AYTU
Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
accessnewswire.com
AYTU